You just read:

Baxalta's BAX 855 Pivotal Data Published in Blood Shows Potential to Provide Strong Bleed Prevention with Twice Weekly Dosing for Patients with Hemophilia A

News provided by

Nektar Therapeutics

Jul 16, 2015, 03:36 ET